BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2059321)

  • 1. Quantitative explanation on structure-carcinogenic activity relationship of aromatic amines by di-region theory.
    Dai QH; Zheng QY; Wang ZY
    Sci China B; 1991 May; 34(5):547-59. PubMed ID: 2059321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative pattern recognition for structure-carcinogenic activity relationship of N-nitroso compounds based upon Di-region theory.
    Dai QH; Zhong RG
    Sci China B; 1989 Jul; 32(7):776-90. PubMed ID: 2818816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Researches on chemical carcinogens and mechanism of chemical carcinogenesis. Di-region theory--a quantitative molecular orbital model of carcinogenic activity for polycyclic aromatic hydrocarbons.
    Qianhuan D
    Sci Sin; 1980 Apr; 23(4):453-70. PubMed ID: 7403839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultimate carcinogenic metabolites from aromatic and heterocyclic aromatic amines: a computational study in relation to their mutagenic potency.
    Borosky GL
    Chem Res Toxicol; 2007 Feb; 20(2):171-80. PubMed ID: 17261035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenic carbocyclic and heterocyclic aromatic amines: a DFT study concerning their mutagenic potency.
    Borosky GL
    J Mol Graph Model; 2008 Nov; 27(4):459-65. PubMed ID: 18799337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSARs of aromatic amines: identification of potent carcinogens.
    Franke R; Gruska A; Bossa C; Benigni R
    Mutat Res; 2010 Sep; 691(1-2):27-40. PubMed ID: 20600167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural motifs modulating the carcinogenic risk of aromatic amines.
    Benigni R; Worth A; Netzeva T; Jeliazkova N; Bossa C; Gruska A; Franke R
    Environ Mol Mutagen; 2009 Mar; 50(2):152-61. PubMed ID: 19152383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantum chemical studies of the metabolism of polycyclic aromatic amines and the stabilities and electrophilicities of their arylnitrenium ions in relation to their mutagenic/carcinogenic potencies.
    Loew GH; Phillips J; Pack G
    Cancer Biochem Biophys; 1979; 3(3):101-10. PubMed ID: 95393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic studies in vivo with arylamines.
    Weisburger EK
    Natl Cancer Inst Monogr; 1981 Dec; (58):95-9. PubMed ID: 7341987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fisher discriminant analysis for carcinogenic potency of aromatic amines].
    Zhu Y; Yu Y; Chen X
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Jan; 33(1):21-5. PubMed ID: 11864450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationships model.
    Franke R; Gruska A; Giuliani A; Benigni R
    Carcinogenesis; 2001 Sep; 22(9):1561-71. PubMed ID: 11532881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of aromatic amines and azo dyes.
    Bartsch H
    IARC Sci Publ; 1981; (40):13-30. PubMed ID: 6799396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical studies on the carcinogenicity of polycyclic aromatic hydrocarbons.
    Vijayalakshmi KP; Suresh CH
    J Comput Chem; 2008 Aug; 29(11):1808-17. PubMed ID: 18351614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.
    Talaska G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2003 May; 21(1):29-43. PubMed ID: 12826031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantum mechanical approach to the theory of cancer from polynuclear compounds. Metabolic activation and carcinogenicity of extended anilines and aminoazo compounds.
    Mohammad SN
    Mol Pharmacol; 1985 Jan; 27(1):148-55. PubMed ID: 3965927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-carcinogenic activity relationship of methyl, alkyl, cyclopentano, cyclohexano polycyclic aromatic hydrocarbons and cholanthrene series.
    Dai QH; Tai CH; Zhang DX
    Sci Sin B; 1985 Feb; 28(2):160-87. PubMed ID: 4012262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some properties of aromatic amines].
    Dubini M
    G Ital Med Lav; 1982; 4(4-5):227-30. PubMed ID: 7185642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based structure-activity relationship (SAR) analysis of aromatic amines and nitroaromatics carcinogenicity via statistical analyses based on CPDB.
    Wan WX; Chen Y; Zhang J; Shen F; Luo L; Deng SH; Xiao H; Zhou W; Deng OP; Yang H; Xiao YL; Huang CR; Tian D; He JS; Wang YJ
    Toxicol In Vitro; 2019 Aug; 58():13-25. PubMed ID: 30878698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Substituted aryl compounds in carcinogenesis and mutagenesis.
    Weisburger EK
    Natl Cancer Inst Monogr; 1981 Dec; (58):1-7. PubMed ID: 7341965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.